HETLIOZ 20 mg hard capsules, Placebo will be provided in size and appearance identical to those containing tasimelteon and will be administered orally.
VP-VEC-162-3502
Phase 3 small_molecule active
Quick answer
HETLIOZ 20 mg hard capsules, Placebo will be provided in size and appearance identical to those containing tasimelteon and will be administered orally. for Delayed Sleep-Wake Phase Disorder (DSWPD) is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Delayed Sleep-Wake Phase Disorder (DSWPD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active